Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Males and females, aged 18 to 65.
Adequate hepatic function.
Documented creatinine clearance by Cockroft-Gault formula indicative of the respective level of renal impairment: Severe renal impairment (CrCl \<30 mL/min/1.73m2), moderate renal impairment (30 ≤ CrCl ≤50 mL/min/1.73m2), mild renal impairment (50 \< CrCl≤80 mL/min/1.73m2) and normal renal function (CrCl \>80 mL/min/1.73m2).
You may not be if
Use of any investigational drug or biologic within 4 weeks prior to the screening visit of during the screening period.
Ongoing treatment with Digoxin or strong CYP3A4 inhibitors or inducers.